Association of British Clinical Diabetologists (ABCD) and Diabetes UK joint position statement and recommendations for non-diabetes specialists on the use of sodium glucose co-transporter 2 inhibitors in people with type 2 diabetes (January 2021).
ABCD
Diabetes UK
SGLT2 inhibitors
non-diabetes specialists
type 2 diabetes
Journal
Clinical medicine (London, England)
ISSN: 1473-4893
Titre abrégé: Clin Med (Lond)
Pays: England
ID NLM: 101092853
Informations de publication
Date de publication:
05 2021
05 2021
Historique:
entrez:
18
5
2021
pubmed:
19
5
2021
medline:
21
5
2021
Statut:
ppublish
Résumé
Sodium glucose co-transporter 2 (SGLT2) inhibitors are now an established class of medications for the treatment of type 2 diabetes (T2D), no longer reserved for use by specialists in diabetes. They are being used increasingly for their cardiac and renal benefits by primary care, cardiology and renal teams for indications in parallel with diabetes care as part of holistic management. This guidance provides essential information on SGLT therapy, including the main advantages and the important risks of which healthcare professionals should be aware.
Identifiants
pubmed: 34001571
pii: 21/3/204
doi: 10.7861/clinmed.2021-0045
pmc: PMC8140708
doi:
Substances chimiques
Hypoglycemic Agents
0
Sodium-Glucose Transporter 2 Inhibitors
0
Symporters
0
Sodium
9NEZ333N27
Glucose
IY9XDZ35W2
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
204-210Informations de copyright
© Royal College of Physicians 2021. All rights reserved.
Références
N Engl J Med. 2020 Oct 8;383(15):1436-1446
pubmed: 32970396
N Engl J Med. 2020 Oct 8;383(15):1413-1424
pubmed: 32865377
Rev Endocr Metab Disord. 2020 Dec;21(4):613-629
pubmed: 32128655
Nat Rev Dis Primers. 2020 May 14;6(1):40
pubmed: 32409703
J Am Soc Nephrol. 2013 Feb;24(2):302-8
pubmed: 23362314
Diabetes Care. 2020 Feb;43(2):487-493
pubmed: 31857443
Diabet Med. 2011 May;28(5):508-15
pubmed: 21255074
Diabetes Care. 2020 Jan;43(Suppl 1):S14-S31
pubmed: 31862745
Lancet. 2019 Jan 5;393(10166):31-39
pubmed: 30424892
N Engl J Med. 2017 Aug 17;377(7):644-657
pubmed: 28605608
Lancet Diabetes Endocrinol. 2018 May;6(5):349-352
pubmed: 29483059
Curr Med Chem. 2020;27(39):6682-6702
pubmed: 31663470
N Engl J Med. 2020 Oct 8;383(15):1425-1435
pubmed: 32966714
N Engl J Med. 2019 Nov 21;381(21):1995-2008
pubmed: 31535829